Generics Products found!

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Dicyclomaine manufacturers

Filters

Filters

Filters , active

Country of origin : India

Clear all

None products found

dicyclomaine

Vials 10 mg/ml - 10 ml, 30 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #35915

Established in 2007, this family-owned manufacturer specializes in pharmaceutical formulations, offering over 500 products across various dosage forms, including tablets, capsules, dry syrups, ointments, dry injections, and liquid orals. As a CTD dossier owner and manufacturer, it holds WHO-cGMP certification, ensuring compliance with stringent international quality standards. The manufacturer operates advanced production lines with capacities such as 3,600 million tablets, 1,800 million capsules, 240 million liquid injections in ampoules, and 70 million dry powder injections per annum, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide.

Manufacturer usually replies in 7 days

dicyclomaine + paracetamol

Tablets 20 mg + 325 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17641
The company is an emerging pharmaceutical player focused on providing access to affordable medicines across both emerging and developed markets globally. With state-of-the-art manufacturing facilities accredited by regulatory authorities, the company specializes in a wide range of high-tech, specialized products that are challenging to formulate. Its diverse portfolio includes APIs, granules, pellets, veterinary care products, finished formulations, herbal products, hospital supplies, and pharmaceutical packaging. Committed to collaboration and building mutually beneficial relationships, the company adheres to international standards, holding WHO-GMP and ISO 9001:2015 certifications to ensure quality and compliance.

Manufacturer usually replies in 5 days

diclofenac sodium + dicyclomaine

Injection 50 mg + 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #21177

This CTD dossier owner and manufacturer, established in the 1980s, operates within South Asia, specializing in the manufacture and supply of pharmaceutical products. Their offerings include tablets, capsules, eye, ear, and nasal drops, as well as oral and injectable suspensions. The company holds EU and US GMP approvals, signifying adherence to high manufacturing standards. Their production lines cater to a diverse range of therapeutic areas, with a focus on infectious diseases, pain management, and ophthalmology. The company boasts a sizable workforce and has a global reach, catering to markets across the world. They are recognized for their commitment to quality, utilizing high-grade chemicals and advanced machinery for production. The company emphasizes its track record in providing quality pharmaceutical products, underscoring its experience in the industry.

Manufacturer usually replies in 2 days

Want to see all products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.